Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarker modulation in a nonhuman rhesus primate model for ovarian cancer chemoprevention.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Aug 2001

Brewer M, Utzinger U, Satterfield W, Hill L, Gershenson D, Bast R, Wharton J T, Richards-Kortum R, Follen M

Abstract excerpt

OBJECTIVE: The objective of this study was to explore whether a nonhuman primate model could be developed to test drugs for the prevention of ovarian cancer. METHODS: Nineteen adult female Rhesus macaques were given fenretinide (4HPR), oral contraceptives (OCP), the combination (4HPR + OCP), or n...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Chemoprevention

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Contraceptives, Oral

Share to Disease Models, Animal

Share to Macaca mulatta

Share to Ovarian Neoplasms

Share to Phenotype

Share to Spectrometry, Fluorescence

Source

Identifiers

PMID: 11489756

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-11489756-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Biomarker modulation in a nonhuman rhesus primate model for ovarian cancer chemoprevention.PMID 11489756Read ↗

Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk?Semantic proximity Read ↗

4-Oxo-Fenretinide, a Recently Identified Fenretinide Metabolite, Induces Marked G2-M Cell Cycle Arrest and Apoptosis in Fenretinide-Sensitive and Fenretinide-Resistant Cell LinesSemantic proximity Read ↗

Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial.Semantic proximity Read ↗

Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia.Semantic proximity Read ↗

Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expressionSemantic proximity Read ↗

Effects of retinoids on cancerous phenotype and apoptosis in organotypic cultures of ovarian carcinoma.Semantic proximity Read ↗

N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.Semantic proximity Read ↗

Proliferation of microvascular endothelial cells in the primate corpus luteum during the menstrual cycle and simulated early pregnancy.Semantic proximity Read ↗

Effect of early vs. late administration of 4-hydroxyphenylretinamide (4-HPR) on N-methyl-N-nitrosourea (MNU)-induced mammary tumorigenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.